Biotrin's lead product range includes tests to detect Parvovirus B19, a viral infection that can cause miscarriage in pregnant women. Biotrin is the world leader in Parvovirus B19 testing and the only company to have FDA approved tests. The company also provides a range of CE marked tests for other emerging viruses, including HHV-6 and HHV-8.

Biotrin's headquarters are in Dublin, Ireland, where it conducts its R&D, manufacturing and marketing activities. The company sells directly in the U.S.A. and employs a network of over 40 distributors worldwide. The company currently employs 70 people and is EN46001 / ISO13485 certified.

Biotrin's Quality Charter

Biotrin is committed to providing consistently high quality diagnostic assays that will perform to our customers' expectations. We endeavour to achieve our goals of continuous quality improvement and meeting our customers needs by:

· Continuously improving all aspects of our business
· Improving customer service through product definition, design and technical support.
· Involving all employees in our continuous quality improvement efforts
· Consistently meeting and exceeding all European and world wide statutory and regulatory requirements
· Protecting and enhancing the quality of our products through compliance with CGMP and IVD regulatory requirements

Biotrin International Ltd is a FDA registered site, with compliance to ISO13485, Canadian Medical Devices Conformity Assessment System and the 98/79/EC IVD Directive.